Trial Details
RECRUITINGBasic Information
| Clinical ID | c670 |
|---|---|
| Identifier | NCT06249555 |
| Trial Title | VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab (VDZ)|DRUG: Ustekinumab (UST)|DRUG: Risankizumab (RISA)|DRUG: Guselkumab (GUS)|DRUG: Mirikizumab (MIR) |
Participant Information
| Sponsor | Alimentiv Inc. |
|---|---|
| City | Sun City |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2024-03-20 |
|---|---|
| Primary Completion Date | 2026-06 |
| Completion Date | 2026-12 |